 | • レポートコード：MRC2-11QY11097 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオシミラー試験・開発サービスのグローバル市場について調査・分析したレポートです。種類別（エフェクター結合、ELISA、キネティック結合アッセイ、ADCC・CDC細胞ベースアッセイ）市場規模、用途別（PKアッセイ、階層型免疫原性試験、NAbアッセイ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオシミラー試験・開発サービスの競争状況、市場シェア ・世界のバイオシミラー試験・開発サービス市場：種類別市場規模 2015年-2020年（エフェクター結合、ELISA、キネティック結合アッセイ、ADCC・CDC細胞ベースアッセイ） ・世界のバイオシミラー試験・開発サービス市場：種類別市場規模予測 2021年-2026年（エフェクター結合、ELISA、キネティック結合アッセイ、ADCC・CDC細胞ベースアッセイ） ・世界のバイオシミラー試験・開発サービス市場：用途別市場規模 2015年-2020年（PKアッセイ、階層型免疫原性試験、NAbアッセイ） ・世界のバイオシミラー試験・開発サービス市場：用途別市場規模予測 2021年-2026年（PKアッセイ、階層型免疫原性試験、NAbアッセイ） ・北米のバイオシミラー試験・開発サービス市場分析：米国、カナダ ・ヨーロッパのバイオシミラー試験・開発サービス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオシミラー試験・開発サービス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオシミラー試験・開発サービス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオシミラー試験・開発サービス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eurofins Scientific、SGS、Charles River Laboratories、Pharmaceutical Product Development、Exova、Source BioScience、Intertek Group、Medistri、Pace Analytical Services、Sigma-Aldrich ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
Market Analysis and Insights: Global Biosimilar Testing and Development Services Market
The global Biosimilar Testing and Development Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biosimilar Testing and Development Services Scope and Market Size
Biosimilar Testing and Development Services market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Testing and Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Market segment by Type, the product can be split into
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Market segment by Application, split into
PK assay
Tiered Immunogenicity testing
NAb assays
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
1.4 Market by Type
1.4.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Effector Binding
1.4.3 ELISA
1.4.4 Kinetic Binding Assays
1.4.5 ADCC & CDC Cell-Based Assays
1.5 Market by Application
1.5.1 Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2026
1.5.2 PK assay
1.5.3 Tiered Immunogenicity testing
1.5.4 NAb assays
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2015-2026)
2.2 Global Biosimilar Testing and Development Services Growth Trends by Regions
2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biosimilar Testing and Development Services Market Growth Strategy
2.3.6 Primary Interviews with Key Biosimilar Testing and Development Services Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing and Development Services Players by Market Size
3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2015-2020)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2015-2020)
3.1.3 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.2.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2019
3.3 Biosimilar Testing and Development Services Key Players Head office and Area Served
3.4 Key Players Biosimilar Testing and Development Services Product Solution and Service
3.5 Date of Enter into Biosimilar Testing and Development Services Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2015-2020)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biosimilar Testing and Development Services Market Size by Application (2015-2020)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2015-2020)
6.2 Biosimilar Testing and Development Services Key Players in North America (2019-2020)
6.3 North America Biosimilar Testing and Development Services Market Size by Type (2015-2020)
6.4 North America Biosimilar Testing and Development Services Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2015-2020)
7.2 Biosimilar Testing and Development Services Key Players in Europe (2019-2020)
7.3 Europe Biosimilar Testing and Development Services Market Size by Type (2015-2020)
7.4 Europe Biosimilar Testing and Development Services Market Size by Application (2015-2020)
8 China
8.1 China Biosimilar Testing and Development Services Market Size (2015-2020)
8.2 Biosimilar Testing and Development Services Key Players in China (2019-2020)
8.3 China Biosimilar Testing and Development Services Market Size by Type (2015-2020)
8.4 China Biosimilar Testing and Development Services Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biosimilar Testing and Development Services Market Size (2015-2020)
9.2 Biosimilar Testing and Development Services Key Players in Japan (2019-2020)
9.3 Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020)
9.4 Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biosimilar Testing and Development Services Market Size (2015-2020)
10.2 Biosimilar Testing and Development Services Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2015-2020)
10.4 Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2015-2020)
11 India
11.1 India Biosimilar Testing and Development Services Market Size (2015-2020)
11.2 Biosimilar Testing and Development Services Key Players in India (2019-2020)
11.3 India Biosimilar Testing and Development Services Market Size by Type (2015-2020)
11.4 India Biosimilar Testing and Development Services Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biosimilar Testing and Development Services Market Size (2015-2020)
12.2 Biosimilar Testing and Development Services Key Players in Central & South America (2019-2020)
12.3 Central & South America Biosimilar Testing and Development Services Market Size by Type (2015-2020)
12.4 Central & South America Biosimilar Testing and Development Services Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eurofins Scientific
13.1.1 Eurofins Scientific Company Details
13.1.2 Eurofins Scientific Business Overview
13.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
13.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2015-2020))
13.1.5 Eurofins Scientific Recent Development
13.2 SGS
13.2.1 SGS Company Details
13.2.2 SGS Business Overview
13.2.3 SGS Biosimilar Testing and Development Services Introduction
13.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.2.5 SGS Recent Development
13.3 Charles River Laboratories
13.3.1 Charles River Laboratories Company Details
13.3.2 Charles River Laboratories Business Overview
13.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
13.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.3.5 Charles River Laboratories Recent Development
13.4 Pharmaceutical Product Development
13.4.1 Pharmaceutical Product Development Company Details
13.4.2 Pharmaceutical Product Development Business Overview
13.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
13.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.4.5 Pharmaceutical Product Development Recent Development
13.5 Exova
13.5.1 Exova Company Details
13.5.2 Exova Business Overview
13.5.3 Exova Biosimilar Testing and Development Services Introduction
13.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.5.5 Exova Recent Development
13.6 Source BioScience
13.6.1 Source BioScience Company Details
13.6.2 Source BioScience Business Overview
13.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
13.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.6.5 Source BioScience Recent Development
13.7 Intertek Group
13.7.1 Intertek Group Company Details
13.7.2 Intertek Group Business Overview
13.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
13.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.7.5 Intertek Group Recent Development
13.8 Medistri
13.8.1 Medistri Company Details
13.8.2 Medistri Business Overview
13.8.3 Medistri Biosimilar Testing and Development Services Introduction
13.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.8.5 Medistri Recent Development
13.9 Pace Analytical Services
13.9.1 Pace Analytical Services Company Details
13.9.2 Pace Analytical Services Business Overview
13.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
13.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.9.5 Pace Analytical Services Recent Development
13.10 Sigma-Aldrich
13.10.1 Sigma-Aldrich Company Details
13.10.2 Sigma-Aldrich Business Overview
13.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
13.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2015-2020)
13.10.5 Sigma-Aldrich Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biosimilar Testing and Development Services Key Market Segments
Table 2. Key Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
Table 3. Ranking of Global Top Biosimilar Testing and Development Services Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Effector Binding
Table 6. Key Players of ELISA
Table 7. Key Players of Kinetic Binding Assays
Table 8. Key Players of ADCC & CDC Cell-Based Assays
Table 9. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Biosimilar Testing and Development Services Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Biosimilar Testing and Development Services Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Biosimilar Testing and Development Services Market Share by Regions (2015-2020)
Table 13. Global Biosimilar Testing and Development Services Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Biosimilar Testing and Development Services Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Biosimilar Testing and Development Services Market Growth Strategy
Table 19. Main Points Interviewed from Key Biosimilar Testing and Development Services Players
Table 20. Global Biosimilar Testing and Development Services Revenue by Players (2015-2020) (Million US$)
Table 21. Global Biosimilar Testing and Development Services Market Share by Players (2015-2020)
Table 22. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2019)
Table 23. Global Biosimilar Testing and Development Services by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilar Testing and Development Services Product Solution and Service
Table 26. Date of Enter into Biosimilar Testing and Development Services Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 29. Global Biosimilar Testing and Development Services Market Size Share by Type (2015-2020)
Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2021-2026)
Table 31. Global Biosimilar Testing and Development Services Market Size Share by Application (2015-2020)
Table 32. Global Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 33. Global Biosimilar Testing and Development Services Market Size Share by Application (2021-2026)
Table 34. North America Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 36. North America Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 37. North America Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 38. North America Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 39. North America Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 40. Europe Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 42. Europe Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 44. Europe Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 46. China Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 47. China Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 48. China Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 49. China Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 50. China Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 51. China Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 52. Japan Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 54. Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 56. Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 60. Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 62. Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 64. India Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 65. India Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 66. India Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 67. India Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 68. India Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 69. India Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Biosimilar Testing and Development Services Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Biosimilar Testing and Development Services Market Share (2019-2020)
Table 72. Central & South America Biosimilar Testing and Development Services Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Biosimilar Testing and Development Services Market Share by Type (2015-2020)
Table 74. Central & South America Biosimilar Testing and Development Services Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Biosimilar Testing and Development Services Market Share by Application (2015-2020)
Table 76. Eurofins Scientific Company Details
Table 77. Eurofins Scientific Business Overview
Table 78. Eurofins Scientific Product
Table 79. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 80. Eurofins Scientific Recent Development
Table 81. SGS Company Details
Table 82. SGS Business Overview
Table 83. SGS Product
Table 84. SGS Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 85. SGS Recent Development
Table 86. Charles River Laboratories Company Details
Table 87. Charles River Laboratories Business Overview
Table 88. Charles River Laboratories Product
Table 89. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 90. Charles River Laboratories Recent Development
Table 91. Pharmaceutical Product Development Company Details
Table 92. Pharmaceutical Product Development Business Overview
Table 93. Pharmaceutical Product Development Product
Table 94. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 95. Pharmaceutical Product Development Recent Development
Table 96. Exova Company Details
Table 97. Exova Business Overview
Table 98. Exova Product
Table 99. Exova Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 100. Exova Recent Development
Table 101. Source BioScience Company Details
Table 102. Source BioScience Business Overview
Table 103. Source BioScience Product
Table 104. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 105. Source BioScience Recent Development
Table 106. Intertek Group Company Details
Table 107. Intertek Group Business Overview
Table 108. Intertek Group Product
Table 109. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 110. Intertek Group Recent Development
Table 111. Medistri Business Overview
Table 112. Medistri Product
Table 113. Medistri Company Details
Table 114. Medistri Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 115. Medistri Recent Development
Table 116. Pace Analytical Services Company Details
Table 117. Pace Analytical Services Business Overview
Table 118. Pace Analytical Services Product
Table 119. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 120. Pace Analytical Services Recent Development
Table 121. Sigma-Aldrich Company Details
Table 122. Sigma-Aldrich Business Overview
Table 123. Sigma-Aldrich Product
Table 124. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2015-2020) (Million US$)
Table 125. Sigma-Aldrich Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2020 VS 2026
Figure 2. Effector Binding Features
Figure 3. ELISA Features
Figure 4. Kinetic Binding Assays Features
Figure 5. ADCC & CDC Cell-Based Assays Features
Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2026
Figure 7. PK assay Case Studies
Figure 8. Tiered Immunogenicity testing Case Studies
Figure 9. NAb assays Case Studies
Figure 10. Biosimilar Testing and Development Services Report Years Considered
Figure 11. Global Biosimilar Testing and Development Services Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Biosimilar Testing and Development Services Market Share by Regions: 2020 VS 2026
Figure 13. Global Biosimilar Testing and Development Services Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Biosimilar Testing and Development Services Market Share by Players in 2019
Figure 16. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2019
Figure 18. North America Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Biosimilar Testing and Development Services Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
睡眠検査サービスの世界市場（～2026年） Sleep testing is a diagnostic test that helps determine whether you have obstructive sleep apnea. The sleep testing services market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global…- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 電気試験サービスの世界市場（～2026年） Market Analysis and Insights: Global Electrical Testing Services Market The global Electrical Testing Services market size is projected to reach US$ 3880.1 million by 2026, from US$ 3713.9 million in 2020, at a CAGR of 4.1%% during 2021-2026. Global Electrical Testing Services Scope and Market Size …
- 化学試験サービスの世界市場（～2026年） Market Analysis and Insights: Global Chemical Testing Services Market The global Chemical Testing Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemical Testing Services Scope and Market Size Chemical Testin…
- 遺伝子検査サービスの世界市場（～2026年） Genetic test is a type of medical test which analyzes the changes in chromosomes, proteins, or genes, which may be caused by any suspected genetic condition or disease. Market Analysis and Insights: Global Genetic Testing Services Market The global Genetic Testing Services market size is projected t…